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An individual’s genetic makeup plays an important role in determining susceptibility to cognitive aging.
Identifying the speciﬁc genes that contribute to cognitive aging may aid in early diagnosis of at-risk
patients, as well as identify novel therapeutics targets to treat or prevent development of symptoms.
Challenges to identifying these speciﬁc genes in human studies include complex genetics, difﬁculty in
controlling environmental factors, and limited access to human brain tissue. Here, we identify Hp1bp3 as
a novel modulator of cognitive aging using a genetically diverse population of mice and conﬁrm that
HP1BP3 protein levels are signiﬁcantly reduced in the hippocampi of cognitively impaired elderly
humans relative to cognitively intact controls. Deletion of functional Hp1bp3 in mice recapitulates
memory deﬁcits characteristic of aged impaired mice and humans, further supporting the idea that
Hp1bp3 and associated molecular networks are modulators of cognitive aging. Overall, our results
suggest Hp1bp3 may serve as a potential target against cognitive aging and demonstrate the utility of
genetically diverse animal models for the study of complex human disease.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Aging is associated with a decline in cognitive performance that
begins aroundmidlife (i.e., 45e50 years), but the onset and severity
varies greatly among individuals (Davies et al., 2015; Singh-Manoux
et al., 2012). Although variation in cognitive performance at midlife
is highly heritable [i.e., 62%e78% of variance is attributable to
genetic factors (McClearn et al., 1997; Plomin and Deary, 2015)], a
large portion of this heritability remains unexplained by currently
identiﬁed gene variants (Johnson et al., 2016). Several studies have
identiﬁed associations between apolipoprotein E, brain-derivedand Neurobiology, University
uite 515, Memphis, TN 38163,
ski).
Inc. This is an open access article uneurotrophic factor, and catechol-O-methyltransferase with either
cognitive ability or rate of cognitive decline in older people (Harris
and Deary, 2011; Laukka et al., 2013; Payton, 2009; Tapia-Arancibia
et al., 2008; Wisdom et al., 2011). However, even when
polymorphisms in these genes are signiﬁcantly associated with
cognitive phenotypes, effect sizes are typically small (Harris and
Deary, 2011), indicating that additional genes contribute signiﬁ-
cantly to the regulation of cognitive decline in human populations.
The identiﬁcation of speciﬁc genes that modify the development
and progression of cognitive decline may aid in early diagnosis of
at-risk patients, as well as identify novel targets for the develop-
ment of therapeutics to prevent or delay the onset of disease.
Challenges to identifying DNA variants that modify cognitive
aging in humans include substantial genetic heterogeneity, difﬁ-
culty in controlling environmental factors, and limited molecular
data from disease-relevant human brain tissue. To circumvent some
of these challenges, murine genetic reference panels (GRPs) havender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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complexity of human populations (International HapMap et al.,
2010; Peirce et al., 2004; Williams et al., 2001), allowing a
researcher to exploit phenotypic heterogeneity across a population
while controlling for environmental factors (Williams and Auwerx,
2015). One such model, a well-characterized GRP known as the
BXDs (Peirce et al., 2004; Taylor, 1978; Taylor et al., 1999), was
derived by crossing 2 common inbred strains, C57BL/6J (B6) and
DBA/2J (D2). The BXDs have been successfully used to identify
genomic regions important for determining learning and memory
capabilities early in life (Wehner et al., 1997) but have not yet been
used to study cognitive aging. To identify genes and molecular
pathways regulating memory capabilities during aging, here we
perform a forward systems genetic analysis on an aged cohort of
strains from the BXD GRP.
2. Methods
2.1. Animals
Male and female mice were group housed (2e5 per cage) and
maintained in colony housing (12-hour light/dark cycle) with ad
libitum access to food and water. All mouse experiments were
conducted in accordance with the University of Tennessee Health
Science Center Animal Care and Use Committee, the Institutional
Committee on Animal Care and Use at the Hebrew University of
Jerusalem, and the National Institutes of Health Guide for the CareA
C
B
Chromosome
Fig. 1. Identiﬁcation of Hp1bp3 as top candidate modulator of cognitive aging. (A) The BXD
intercross. (B) Contextual fear memory (CFM) varies widely across 21 BXD strains (n ¼ 2e8 p
spent freezing during 10 minute test. (C) Genetic interval mapping revealed a signiﬁcant CFM
wide statistical signiﬁcance (p ¼ 0.05), green additive effect line: D parental allele increases
sequence variant. (D) Hp1bp3 expression is highly correlated with CFM across BXD strains
hippocampal Hp1bp3 and poorer CFM. Abbreviation: QTL, quantitative trait locus.and Use of Laboratory Animals. Middle-agedmice (15 0.3months,
2e8 mice per strain) from 21 BXD recombinant inbred strains were
phenotyped. Although experiments in rodents using a single inbred
strain are often carried out using 7e12 replicates (Kaczorowski and
Disterhoft, 2009; Kaczorowski et al., 2011, 2012), mapping studies
using the BXD panel gain much more power by increasing numbers
of unique genotypes rather than replicates per strain (Belknap,
1998). This is because at each locus, roughly half of the lines
inherit B/B genotypes and the other half D/D genotypes (see Fig. 1B
in Andreux et al., 2012). The BXDs were derived by inbreeding the
F2 progeny of a C57BL/6J (B6) and DBA/2J (D2) intercross to create a
panel that models some of the genetic complexity of human pop-
ulations (Chesler et al., 2005; International HapMap et al., 2010).
The parental strains, B6 and D2, differ in a variety of traits, including
memory function (Balogh et al., 2002), amyloid precursor protein
processing (Lehman et al., 2003), adult hippocampal neurogenesis
(Kempermann et al., 2006), and hippocampal excitability (Oksman
et al., 2005), which confers wide phenotypic variability to the
resulting BXD strains. Each BXD line has been inbred for >20 gen-
erations, and their genomes are stable, which allows for replication
studies across time and laboratories (Peirce et al., 2004). In addition
to collected “health records” at GeneNetwork.org, both genotype
and transcriptome data for w40 tissues and cells, including hip-
pocampus, have been generated for many of the strains, which we
combined with full-sequence genome data for both B6 and D2 to
facilitate genetic mapping to identify individual genetic variants
that correlate with traits of interest (Chesler et al., 2005;D
panel was derived by inbreeding the F2 progeny of a C57BL/6J (B6) and DBA/2J (D2)
er strain, mean age ¼ 15  0.3 months). Memory index was quantiﬁed by percent time
QTL on mouse chromosome 4 (Chr4: 137.5e140.5 Mb). Pink horizontal line: genome-
trait values, red: B allele increases trait values. Yellow tick marks: presence of genome
(Pearson r ¼ 0.6, p < 0.05), with strains inheriting the D allele having lower levels of
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mice (n ¼ 6/group) were acquired from the European Conditional
Mouse Mutagenesis program and are described elsewhere
(Garﬁnkel et al., 2015a).
2.2. Contextual fear conditioning
All mice were habituated to transport for at least 3 days before
behavioral tests. On the fourth day, mice were trained on a standard
contextual fear conditioning paradigm (Neuner et al., 2015). Brieﬂy,
contextual fear conditioning consisted of a 180-second baseline
period followed by 4 mild foot shocks (1 second, 0.9 mA, intershock
interval 115  20 seconds). The average activity burst following
each shock was determined by manual timing and used to quantify
the postshock reactivity for each mouse to ensure no difference in
pain sensitivity. Twenty-four hours later, hippocampus-dependent
contextual fear memory (Chen et al., 1996) was tested in a
10-minute session. Behavioral freezing, an index of conditioned
fear, was measured using Freeze Frame software (Coulbourn
Instruments, PA, USA) at the University of Tennessee or EthoVision
software (Noldus Information Technology, Netherlands) at the
Hebrew University of Jerusalem. Our laboratory has previously
demonstrated that measures of freezing obtained via video moni-
toring software correlates well with hand-scored measures of
freezing (Kaczorowski et al., 2012). Experimenters were blind to the
genotype during behavioral tests and data analysis.
2.3. Calculation of memory index for adult BXD strains
BXD strains aged 8e9 weeks had previously been subjected to
contextual fear conditioning by Philip et al. (2010). The data set
used in our study (including males and females) is publically
available on GeneNetwork.org as BXD Published Phenotypes Re-
cord ID 11908. The memory index used in Trait 11908 is a measure
of activity (beam breaks) throughout contextual fear memory
(CFM) testing. This measure of activity has been previously shown
to correlate well with measures of hand-scored freezing behavior
(Valentinuzzi et al., 1998). As the dynamic range of human-
observed freezing behavior is 0%e100% (Anagnostaras et al.,
2000), and an activity score of zero is equivalent to 100% freezing,
we subtracted these activity measures from 100 to obtain a mea-
sure of inactivity that parallels the CFM index (% freezing) calcu-
lated for middle-aged strains. Speciﬁcally, the mean time each adult
BXD strain spent active during testing was subtracted from 100 to
obtain a measure of inactivity. The genotype of each strain at the
Hp1bp3 locus was then obtained from GeneNetwork.org and used
for genotype-by-memory analyses.
2.4. T-maze
The T-maze test was performed as described previously (Deacon
and Rawlins, 2006). Mice were given 10 minutes to habituate to the
testing room. The T-maze ﬂoor was coated with fresh woodchips
before each round of trials. Mice were placed into the T-maze and
allowed to choose 1 of 2 “goal” arms. The mouse was then conﬁned
to that arm for 30 seconds using a central partition. The mice were
removed from the maze and immediately placed back at the
starting point, the partition removed, and the mouse allowed to
choose between the 2 goal arms again (Deacon and Rawlins, 2006).
An “alternation” occurred when the mouse entered the opposite
arm than that towhich it was just conﬁned. The criterion point used
was whole animal in goal arm, including tail tip. A total of 6 trials
were performed, with animals tested no more than twice a day. The
alternation scores across all 6 trials were averaged to obtain an
average alternation score for each mouse.2.5. Quantitative trait locus (QTL) identiﬁcation and candidate gene
selection
After CFM tests for 21 BXD strains were completed, the mean
time spent freezing was averaged for each strain. Strainmeanswere
entered in GeneNetwork.org and are publically available as BXD
Published Phenotypes Record ID: 18395. Hippocampal transcript
data from aged BXD strains available on GeneNetwork.org as UTHSC
BXD Aged Hippocampus Affy MoGene1.0ST (May15) RMA Gene Level,
were used to identify cis (locally)-regulated genes (Andreux et al.,
2012; Chesler et al., 2005) from within intervals of interest. The
same transcript data were used to identify genes whose expression
correlated with memory function in aged animals. Only probes that
did not overlap single nucleotide polymorphisms (SNPs) were used
to avoid hybridization artifacts that may cause apparent differences
in expression due to technical rather than biological variance.
When multiple SNP-free gene level probes were available (e.g.,
Hp1bp3), the mean expression of exon-targeting probes was used.
In cases where SNP-free gene level probes were not available, exon-
level hippocampal transcript data from aged BXD strains were used
(UTHSC BXD Aged Hippocampus Affy Mouse Gene1.0ST (Sep12) RMA
Exon Level, data set accession ID GN392). If exon level probes were
used, the probe with highest average expression across all strains
was selected. All probes were veriﬁed by BLAT (UCSC Genome
Browser). Correlation analyses for initial candidate gene prioriti-
zation used Spearman’s rho and were adjusted for multiple com-
parisons using Bonferroni correction (95% CI).
2.6. Western blots
Western blots were performed as previously described (Hatﬁeld
et al., 2015; Neuner et al., 2015). Frozen human hippocampal
samples (n¼3/group) collected postmortem were obtained from
the University of Kentucky Sanders-Brown Center on Aging and
stored at 80 C until use. Brieﬂy, hippocampal lysates were pre-
pared from frozen tissue, protein concentration was determined
using a Nanodrop2000 Spectrophotometer (ThermoScientiﬁc), and
20 mg of total protein was loaded and separated on a 10% SDS-PAGE
gel. Proteins were transferred using the Bio-Rad TurboTransfer
system and blocked for 30 minutes at room temperature. Primary
antibodies for HP1BP3 and GAPDH (ProteinTech #24556-1-AP and
Fitzgerald #10R-G109a, respectively) were incubated overnight and
detected by anti-mouse and anti-rabbit ﬂuorescent-conjugated
antibodies. Visualization was performed using an Odyssey image
scanner and blots were quantiﬁed using the Odyssey software
version 5.0 (LiCOR). Results were replicated in 2 independent
Western blots. Observed double-band staining is the typical
expression pattern for HP1BP3 (Garﬁnkel et al., 2015b) and overlaps
with positive control HP1BP3 overexpression lysate from human
293Tcells (Abnova #H00050809-T02), which was used as a positive
control. Loading dyeeonly lanes served as negative control.
2.7. Gene set enrichment analysis
Gene set enrichment analysis was performed as described pre-
viously using version 2.2.0 (Mootha et al., 2003; Subramanian et al.,
2005). Brieﬂy, all nominally signiﬁcant correlates of hippocampal
Hp1bp3 were extracted from whole-genome hippocampal tran-
script data from BXD strains age-matched to those used for
contextual fear conditioning. Correlates were ranked based on
correlation coefﬁcient, and this preranked list was used to calculate
an enrichment score for gene sets obtained from the Molecular
Signatures Database version 5.0. Enrichment scores are obtained by
calculating a cumulative (“running-sum”) statistic, which is
increased when a gene is present in the set being tested and
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mulative score from 0 is the enrichment score. Then, normalized
enrichment scores were obtained to account for the size of the gene
set being tested. The proportion of false positives was controlled
using establishedmethods (Mootha et al., 2003; Subramanian et al.,
2005). Based on these criteria, any gene set with a false discovery
rate of 0.25 was accepted as signiﬁcantly enriched in our data set.2.8. Statistical analysis
Statistical analysis was performed using SPSS software (IBM)
and Microsoft Excel. Analyses included independent t-tests,
repeated measures, 1-way and 2-way analysis of variance, and
Pearson correlation with conﬁdence level set at p < 0.05. All ana-
lyses were corrected for multiple comparisons and described in the
Section 3. Unless otherwise stated, data values reported here are
given as mean  standard error of the mean. The order of behav-
ioral tests and mice allocated to each condition were randomized.
The experimenter was blind to group allocation for all behavioral
studies, and analysis of raw data was conducted blind to experi-
mental groups.3. Results
3.1. Genetic mapping identiﬁes an interval on chromosome 4
associated with memory status at midlife
To identify genes involved in the regulation of cognitive aging,
we analyzed hippocampus-dependent memory function across a
cohort of middle-agedmice (15 0.3m) that model the genetic and
phenotypic variation of human populations (the BXD genetic
reference panel, Fig.1A). Speciﬁcally, micewere trained on standard
contextual fear conditioning (Kaczorowski and Disterhoft, 2009).
During training on day 1, mice received 4 scrambled foot shocks in
the conditioning chamber over a 10-minute training session.
Twenty-four hours later, mice were returned to the original con-
ditioning chamber, and the percentage of time each mouse spent
freezing over the 10-minute test was measured as an index of CFM.
CFM is highly variable across this aged BXD family (21 strains
tested, n ¼ 2e8 mice/strain, Fig. 1B), and heritability estimates that
compare the observed genetic (between-strain) variance to tech-
nical (within-strain) variance (heritability, h2 z 0.7) demonstrate
that much of this variability is attributable to genetic factors.Table 1
Locally (cis) regulated positional candidates
Gene symbol Description SNP cou
Hp1bp3 Heterochromatin protein 1 binding protein 3 106
Eif4g3 Eukaryotic translation initiation factor 4 gamma 3 763
Capzb Capping protein (actin ﬁlament) muscle Z-line, beta 448
Iffo2 Intermediate ﬁlament family orphan 2 225
Padi2 Peptidyl arginine deiminase, type II 132
Kif17 Kinesin family member 17 119
Pla2g2f Phospholipase A2, group IIF 40
Mrto4 MRT4 (messenger RNA turnover 4) homolog
(Saccharomyces cerevisiae)
32
Nbl1 Neuroblastoma, suppression of tumorigenicity 1 10
Camk2n1 Calcium/calmodulin-dependent protein kinase II inhibitor 1 4
Genes located under the signiﬁcant CFM QTL were ﬁrst prioritized for presence of annotat
data from aged BXD strains were then used to perform expression QTL mapping, and tho
regulated genes) were given higher priority. These genes were tested for correlation with
where necessary, see Section 2.5). Spearman’s rho correlations are reported.
Key: CFM, contextual fear memory; LRS, likelihood ratio statistic; N.S., not signiﬁcant; Q
a Denotes SNP-free probe.Although strain-speciﬁc differences in acquisition were also
observed, the variance in acquisition was not sufﬁcient to explain
the differences in CFM across the panel.
Subsequent interval mapping using the average memory index
for each strain highlighted a region of chromosome 4 (Chr 4,
137.7e140.5 Mb) that was signiﬁcantly associated with variation in
CFM inmiddle-agedmice (Fig.1C). This QTL had not associatedwith
memory function in studies using younger adult sex-matched BXDs
(Philip et al., 2010), suggesting the QTL contains variants that
contribute to variation in cognitive aging as opposed to general
memory function.3.2. Prioritization of positional candidates identiﬁes Hp1bp3 as
putative regulator of cognitive aging across BXD panel
To identify genes located in the QTL that may be causally
involved in regulating CFM abilities at midlife, positional gene
candidates were prioritized based on the following: (1) annotated
sequence differences segregating among the BXD strains, (2) local
control of gene expression as determined by expression QTL anal-
ysis using hippocampal transcriptome data from aged BXD strains,
and (3) signiﬁcant correlation between hippocampal gene expres-
sion and CFM. The gene heterochromatin protein 1 binding protein 3
(Hp1bp3) emerged as the single best positional candidate (Table 1).
Hp1bp3 contains multiple missense variants in coding regions,
numerous noncoding variants, and insertions and/or deletions
predicted to impact protein function, transcriptional regulation
and/or splicing (McLaren et al., 2010; Supplementary Table 1).
Hippocampal Hp1bp3 expression was signiﬁcantly correlated with
CFM status, with those BXD strains inheriting the D parental allele
exhibiting lower levels of Hp1bp3 transcript and worse CFM per-
formance relative to the B allele (Fig. 1D). Although Hp1bp3 geno-
type had no effect on memory status in younger adult mice (age of
8e9 weeks, Fig. 2A, secondary analysis of data from Philip et al.,
2010), strains inheriting the D allele exhibited signiﬁcantly
impaired CFM at midlife (Fig. 2B). Because variation in the CFM
index at midlife was not due to genetic differences in baseline
anxiety or postshock pain sensitivity confounds (Fig. 3), these data
suggest a genotype-by-age interaction in which reductions in
Hp1bp3 expression correspond speciﬁcally to aging-related cogni-
tive impairment (Figs 1e3). In support, the genotype at Hp1bp3 can
account for as much as 52% of the strain variance in CFM perfor-
mance at midlife. However, calculations of genetic variancent Trait ID in gene network Location Max LRS Correlation with CFM
10338180,a 10344447,a
10342675a
Chr 4: 137.7 Chr4: 139.3 r ¼ 0.7, p < 0.05
10509463a Chr4: 137.5 Chr4: 140.2 r ¼ 0.5, N.S.
10509620, 10509628a Chr4: 138.7 Chr4: 138.2 r ¼ 0.4, N.S.
10509777, 10509781a Chr4: 139.1 Chr4: 139.3 r ¼ 0.4, N.S.
10509838, 10509846a Chr4: 140.5 Chr4: 140.5 r ¼ 0.4, N.S.
10509526, 10509532a Chr4: 137.8 Chr4: 138.2 r ¼ 0.1, N.S.
10517646, 10517654a Chr4: 138.3 Chr4: 140.2 r ¼ 0.2, N.S.
10517706, 10517711a Chr4: 138.9 Chr4: 139.9 r ¼ 0.5, N.S.
10517677, 10517681a Chr4: 138.6 Chr4: 138.2 r ¼ 0.5, N.S.
10509568, no
SNP-free probe
Chr4: 138.0 Chr4: 140.5 d
ed sequence variants between parental strains B6 and D2. Whole-genome transcript
se genes whose expression had a peak LRS at the location of the gene (cis, or locally,
the CFM trait using SNP-free probes from gene-level analyses (or exon-level analyses
TL, quantitative trait locus.
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Fig. 2. Effect of Hp1bp3 genotype on CFM status is age-dependent. (A) Memory index
for adult BXDs (age ¼ 8e9 weeks) was calculated using CFM data generated by Philip
et al. (2010) and is publically available on GeneNetwork.org (Trait ID 110908, see
Section 2.3). Parental origin of Hp1bp3 allele did not signiﬁcantly affect memory status
in adulthood (D allele memory index ¼ 81.0  1.3, B ¼84.3  1.3, t[54] ¼ 1.86, p ¼
0.068). (B) Middle-aged (age ¼ 15.0  0.3 months) BXD strains inheriting the D
parental allele performed signiﬁcantly worse on CFM tests than strains inheriting the B
allele (D ¼ 4.8  1.0, B ¼ 41.5  20.7, t[14] ¼ 4.6, p < 0.001). Two-way analysis of
variance revealed a signiﬁcant interaction between genotype and age (F[1,66] ¼ 33.5,
p < 0.001), suggesting that Hp1bp3 genotype inﬂuences memory status in an
age-dependent manner. Abbreviation: CFM, contextual fear memory.
S.M. Neuner et al. / Neurobiology of Aging 46 (2016) 58e6762explained by a QTL are biased upward by an average of 30% due to a
combination of epistatic, genotype-by-environment interactions,
and small sample size (n < 1000) (Beavis, 1998; Wellenreuther and
Hansson, 2016; Wurschum and Kraft, 2014). Therefore, we estimate
that the actual biological heritable variation in CFM at midlife
explained by Hp1bp3 genotype is more likely in the range of
20%e25%.3.3. Functional validation in a knockout (KO) mouse model
conﬁrms novel role for Hp1bp3 in cognitive function
To assess the functional consequence of loss of Hp1bp3 on
hippocampus-dependent learning and memory, we employed a
reverse genetics approach. During CFM training, Hp1bp3 KO and
wild-type (WT)mice (Garﬁnkel et al., 2015a) showed no differences0
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Fig. 3. Differences in CFM were not attributable to baseline freezing or postshock reactivity
1.009, p ¼ 0.47) or (B) length of postshock activity burst (F[20,49] ¼ 1.668, p ¼ 0.07), indi
respectively, across 21 BXD strains tested. Abbreviation: CFM, contextual fear memory.in baseline activity (Fig. 4A) or shock reactivity (Fig. 4B), and KO
mice exhibited comparable acquisition of conditioned fear, indi-
cating they successfully learned the context-shock association
(Fig. 4A). Nevertheless, KO mice exhibited long-term CFM deﬁcits
when tested 24 hours later (Fig. 4C). Notably, the effect of Hp1bp3
KO on CFM was similar to the effect of genotype at the Hp1bp3
locus. As the KO mice were generated on a B6 background, the WT
mice carry the B version of the Hp1bp3 allele, and as expected,
perform comparable to B6 mice from the BXD GRP. However, KO
mice performed more similarly to BXDs harboring the D allele,
which exhibited a 20%e40% reduction in conditioned freezing
during CFM tests compared to strains with the B allele (Fig. 2B). This
suggests the D allele functions similarly to a loss-of-function
mutation.
To determine if loss of Hp1bp3 mimics aging-related effects on
additional hippocampus-dependent cognitive domains (Zornetzer
et al., 1982), working memory was assessed using the T-maze test
of spontaneous alternation (Deacon and Rawlins, 2006). KO mice
were signiﬁcantly impaired relative toWTmice, and like aged mice
(Lalonde, 2002), performed at chance levels (Fig. 4D). Taken
together, these results demonstrate, for the ﬁrst time, that Hp1bp3
is necessary for successful hippocampus-dependent memory
function spanning multiple cognitive domains and suggest that
therapeutic interventions to restore levels of Hp1bp3 may improve
cognitive function.
3.4. Hp1bp3 is associated with memory function in human
cognitive aging
To test the hypothesis that Hp1bp3 is also involved in human
cognitive aging and to evaluate the translational relevance of our
murine results, we next tested whether hippocampal Hp1bp3
expression correlated with cognitive performance in elderly
humans (Table 2). Caveats to working with human brain samples
include variable postmortem intervals and undeﬁned brain pa-
thology (Bennett et al., 2014; Hargis, 2016). Therefore, to limit po-
tential confounds we analyzed hippocampal tissue from humans
with “normal” cognitive aging (i.e., no distinct Alzheimer’s disease
[AD] pathology), which is not typically associated with gross neu-
rodegeneration (Burke and Barnes, 2006; Korbo et al., 2004).
Quantitative Western blots for HP1BP3 were performed on post-
mortem hippocampal tissue lysates prepared from cognitively
intact (mini-mental state examination [MMSE] score ¼ 29.3  0.3,
age ¼ 78  9.7 years) and cognitively impaired humans (MMSE ¼
22.6  3.0, age ¼ 84  4.4 years). HP1BP3 levels were signiﬁcantly0
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Fig. 4. Hp1bp3 knockout (KO) mice exhibit impairment on hippocampus-dependent
long-term CFM and working memory tasks. (A) Comparable baseline (BL) freezing
and acquisition of conditioned fear (Acq. fear) by the ﬁnal trial in wild-type (WT) and
Hp1bp3 KO mice (n ¼ 6 per group) during contextual fear conditioning. (B) There were
no differences in postshock reactivity during fear conditioning training between WT
and Hp1bp3 KO mice, indicating no differences in pain sensitivity. Videos were
manually analyzed to determine the average length of activity burst for each mouse.
WT ¼ 2.6  0.2 seconds, KO ¼ 2.6  0.2 seconds; t(1,10)¼ 0.11, p ¼ 0.91. (C) KO mice
were signiﬁcantly impaired on CFM (t[10] ¼ 3.10, p< 0.001). (D) KO mice also exhibited
spatial working memory deﬁcits (t[12] ¼ 5.095, p < 0.001). *p < 0.05. Abbreviation:
CFM, contextual fear memory.
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with age-matched controls (Fig. 5). Double-band staining is typical
of HP1BP3 expression, indicative of multiple splice variants present
in brain tissue (Garﬁnkel et al., 2015b). These results suggest either
lower or reduced expression of Hp1bp3 may underlie cognitive
deﬁcits observed in human populations and highlight the value and
potential relevance of aged cohorts of diverse strains of mice for
identifying molecular correlates of cognitive decline in humans.
3.5. Genetic correlation analyses elucidate functional roles for
Hp1bp3 in cognitive aging
There is evidence that groups of highly correlated genes are
likely to play a similar biological function and/or act as part of the
same biological pathway (Eisen et al., 1998; Zhang and Horvath,
2005). To identify mechanisms through which Hp1bp3 may act to
regulate cognitive abilities at midlife, genes whose hippocampal
expression signiﬁcantly correlated with that of Hp1bp3 were
identiﬁed using whole-genome hippocampal transcript data from
middle-aged BXD strains. All nominally signiﬁcant correlates (un-
corrected p  0.05, 2074 genes) were sorted into a ranked list, with
the most highly positively correlated genes at the top
(Supplementary Table 2). This list was then used for gene set
enrichment analysis (Broad Institute (Subramanian et al., 2005);
and tested against gene sets publicly available from BroadTable 2
Demographics for elderly humans used for postmortem hippocampal tissue analysis
Patient Age Sex MMSE Group Postmortem interval (h)
H1 79 Female 29 Intact 1.75
H2 93 Female 30 Intact 2.25
H3 81 Male 29 Intact 2.83
H4 86 Female 27 Impaired 2.48
H5 90 Female 24 Impaired 2.5
H6 59 Male 17 Impaired 5.85
Key: MMSE, mini-mental state examination score (maximum score indicating
normal cognition ¼ 30).Institute’s Molecular Signatures Database, including Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways (Kanehisa
and Goto, 2000), Reactome pathways (Matthews et al., 2009), and
Gene Ontology (GO) classiﬁcation (Harris et al., 2004), using a false
discovery rate of 0.25 to identify signiﬁcantly enriched gene sets
per standard methods (Subramanian et al., 2005).
Functions of Hp1bp3 that have been identiﬁed include regula-
tion of chromatin structure (Dutta et al., 2014), gene expression
(Garﬁnkel et al., 2015b), cell cycle progression (Dutta et al., 2014),
and insulin signaling (Garﬁnkel et al., 2015a), several of which were
supported by our analyses. For example, positive correlates of
Hp1bp3 were signiﬁcantly enriched both in nuclear localization
(Fig. 6A) and insulin signaling (Fig. 6B). In addition, we found
Hp1bp3 gene correlates enriched for terms related to plasma
membrane localization and for functions related to neuronal
function and excitability, including voltage-gated channel activity,
ion channel activity, and G-protein coupled receptor activity
(Fig. 6C). Together, these results support the hypothesis that
Hp1bp3 may critically inﬂuence expression of ion channels and
receptors located in the plasma membrane that mediate neuro-
genesis, neuronal excitability, and plasticity; all of which are
mechanisms that are disrupted in hippocampal neurons of aged
rodent models with cognitive deﬁcits (Burke and Barnes, 2006;
Kaczorowski and Disterhoft, 2009; Mattson and Magnus, 2006).
Finally, Hp1bp3 gene correlates also show signiﬁcant overlap with
genes differentially expressed between AD patients and controls
(Blalock et al., 2004; Fig. 6D), suggesting the role of Hp1bp3 in
cognitive aging may extend into the regulation of cognitive deﬁcits
observed in AD.
4. Discussion
The goal of this study was to use a genetically diverse panel of
mice to identify genetic factors involved in the regulation of
cognitive aging that may have gone undetected in either complex
human studies or murine studies utilizing only a single genetic
background. Aging is a leading risk factor for age-associated de-
mentias such as AD, and our work and others suggest that genetic
factors and mechanisms underlying biological processes during
midlife play a key role in determining an individual’s susceptibility
or resilience to transitioning between healthy brain aging and
pathological brain aging (Douaud et al., 2013; Jack et al., 2013;
Kaczorowski et al., 2011; Keller, 2006; Miller et al., 2008). Thus,
there is a critical need to understand gene variants that play a role
in determining memory capabilities at this midlife transition point.
To directly address this need, and to overcome some of the barriers
inherent to human studies, we turned to a well-characterized
murine GRP, which allows for the exploitation of phenotypic het-
erogeneity across a population while exerting precise control of
environmental conditions.
4.1. Identiﬁcation and validation of Hp1bp3 as top positional
candidate modulating cognitive aging
By combining forward and reverse murine genetic approaches
and by joint analysis of mouse and human cohorts, we progressed
from the identiﬁcation of a signiﬁcant QTL containing variants
regulating CFM at midlife to the demonstration that our top posi-
tional candidate,Hp1bp3, is important for hippocampus-dependent
long-term CFM and spatial working memory. Knockout of Hp1bp3
has been associated with viability and growth abnormalities
(Garﬁnkel et al., 2015b) that may affect behavior. Therefore, we
examined the behavior of Hp1bp3 KO mice on 3 tasks that may
confound CFM testing (e.g., baseline exploratory activity, postshock
reactivity, and acquisition of contextual fear). We found no
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sures, suggesting that the effects of Hp1bp3 KO reported herein are
not due to gross behavioral abnormalities. Other positional candi-
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determined by Blalock et al. (2004) to be signiﬁcantly differentially expressed between
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(Chen et al., 1996) and the fact that the hippocampus is one of the
ﬁrst structures affected in aging (Burke and Barnes, 2006; Gant
et al., 2006). However, given that the formation and recall of CFM
involves a distributed network of brain regions (Tovote et al., 2015),
it is possible that altered gene expression in other regions (e.g.,
prefrontal cortex) may also contribute to variation in cognitive
aging. As variation in Hp1bp3 genotype was estimated to account
for w20%e25% of the heritable variation in CFM at midlife, it is
possible that additional genes, acting alone or in combination with
Hp1bp3, also inﬂuence some of the observed variation in cognitive
decline, and further investigation into these candidates is
warranted.
4.2. Hp1bp3 likely plays conserved role in humans
Reduced expression of Hp1bp3 is observed in both cognitively
impaired aged mice and humans, suggesting that decreased
expression of Hp1bp3 contributes to cognitive aging in both species.
In support of this idea, Hp1bp3 is among the top 100 genes upre-
gulated in response tometformin hydrochloride (Lamb et al., 2006),
a drug known to enhance memory in mice (Wang et al., 2012),
which was recently approved for clinical trial to prevent or reduce
effects of aging, including cognitive decline (Targeting Aging with
Metformin, TAME study). In addition, Hp1bp3 is highly conserved in
mammals, with 93% similarity between the human and murine
primary sequences (Garﬁnkel et al., 2015b) indicating Hp1bp3 likely
plays an important functional role in both species. Deletion of the
region of the human genome syntenic to our QTL results in a con-
dition known as deletion 1p36 syndrome (Battaglia et al., 2008).
Although speciﬁc phenotypes vary according to size and location of
deletion breakpoint (Gajecka et al., 2007), manywith this syndrome
exhibit cognitive deﬁcits and mental retardation (Battaglia et al.,
2008), supporting the idea that genes in this area are necessary
for cognitive function in both humans and animals.
4.3. Gene set enrichment analyses highlight putative functional
roles for Hp1bp3
Hp1bp3 has been shown to be evolutionarily and structurally
related to the linker histone H1 family, members of which confer
higher-order organization to chromatin by binding to the surface of
nucleosomes (Garﬁnkel et al., 2015b). A number of studies suggest
this family of proteins plays a highly speciﬁc role in gene expression,
possibly because of their role in chromatin organization (Garﬁnkel
et al., 2015b). It is thought that Hp1bp3 contributes to the inter-
conversion of heterochromatin and euchromatin (Dutta et al.,
2014), thereby activating or silencing speciﬁc genes as needed. As
long-term memory and cognition depend on de novo gene
expression in response to learning and/or training event (Cavallaro
et al., 2002), it is possible thatHp1bp3 is regulating the transcription
of speciﬁc genes necessary for successful cognitive function. Genes
signiﬁcantly positively correlated with Hp1bp3 were enriched for
localization in the nucleus, with functions including transcription
and RNA processing. Genes negatively correlated with Hp1bp3
include genes with known links to cognition and neuron function,
such as channel and transporter activity (Fig. 6C). In addition, genes
effected by Hp1bp3 knockdown in cell lines are known to have
important neuronal and/or memory functions in vivo, including the
regulation of neuronal excitability (Averaimo et al., 2014; Gulledge
et al., 2013; Richards et al., 2007), Ca2þ homeostasis (Jia et al., 2015),
synaptic plasticity (Lee et al., 2012), and inhibitory neurotransmis-
sion (Marsden et al., 2007) in the hippocampus (e.g., Ca2þ ATPase,
Naþ/Kþ ATPase, CLCC1 and CLIC channels, and GABARAP). However,
our gene set enrichment analysis results do not differentiatewhether changes in nuclear or plasma membrane proteins occur
ﬁrst, so it is possible that compensatory changes in transcription
and RNA processing are occurring due to aging-induced alterations
in plasma membrane ion channels and receptors. A targeted in vivo
knockdown of Hp1bp3 and subsequent gene expression analysis
will help to clarify the role of Hp1bp3 in gene expression under
physiological conditions.
5. Conclusion
Here, we demonstrate for the ﬁrst time that Hp1bp3 is a key
modulator of cognitive aging. In addition, although the BXD family
has previously been used to study cognition in young mice (Philip
et al., 2010; Wehner et al., 1997), but Hp1bp3 had not emerged as
a key regulator of CFM, our results suggest that variation in Hp1bp3
genotype may inﬂuence memory in an age-dependent manner. As
biological processes regulating memory function at midlife may
play a critical role in the development of AD dementia (Douaud
et al., 2013; Jack et al., 2013; Kaczorowski et al., 2011; Keller,
2006; Miller et al., 2008) and Hp1bp3 gene correlates also show
signiﬁcant overlap with genes differentially expressed between AD
patients and controls (Blalock et al., 2004; Fig. 6D), we speculate
that treatments that restore Hp1bp3 expression and/or function
may improve cognition in patients with normal cognitive decline as
well as AD dementia. This prediction is further supported by evi-
dence that metformin hydrochloride, a drug known to increase
Hp1bp3 expression (Lamb et al., 2006), has been shown to enhance
memory in mice (Wang et al., 2012) and is approved for an anti-
aging clinical trial in humans (Targeting Aging with Metformin,
TAME study). Overall, our results suggest Hp1bp3 and related net-
works may serve as potential targets against cognitive aging and
demonstrate the utility of genetically diverse mouse models for the
study of complex human disease.
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